MD20080116A - Trusă pentru administrarea parenterală a medicamentelor - Google Patents

Trusă pentru administrarea parenterală a medicamentelor

Info

Publication number
MD20080116A
MD20080116A MDA20080116A MD20080116A MD20080116A MD 20080116 A MD20080116 A MD 20080116A MD A20080116 A MDA20080116 A MD A20080116A MD 20080116 A MD20080116 A MD 20080116A MD 20080116 A MD20080116 A MD 20080116A
Authority
MD
Moldova
Prior art keywords
kit
medicaments
parenteral administration
infusion
administration
Prior art date
Application number
MDA20080116A
Other languages
English (en)
Russian (ru)
Inventor
Флавио Виллани
Паоло Магри
Original Assignee
Infa S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infa S.A. filed Critical Infa S.A.
Publication of MD20080116A publication Critical patent/MD20080116A/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Invenţia se referă la o trusă pentru administrarea parenterală a medicamentelor, în particular pentru infuzia medicamentelor dizolvate în solvenţi, care extrag componentele toxice din clorura de polivinil, trusa fiind, de asemenea, potrivită pentru infuzia medicamentelor extrem de active, asigurând o administrare sigură a lor atât pentru pacient, cât şi pentru personalul medical.
MDA20080116A 2005-09-29 2006-09-29 Trusă pentru administrarea parenterală a medicamentelor MD20080116A (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001826A ITMI20051826A1 (it) 2005-09-29 2005-09-29 Kit per la somministrazione parenterale di medicamenti
PCT/IB2006/002702 WO2007036792A2 (en) 2005-09-29 2006-09-29 Kit for parenteral administration of medicaments

Publications (1)

Publication Number Publication Date
MD20080116A true MD20080116A (ro) 2008-10-31

Family

ID=37900123

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20080116A MD20080116A (ro) 2005-09-29 2006-09-29 Trusă pentru administrarea parenterală a medicamentelor

Country Status (27)

Country Link
US (1) US8182449B2 (ro)
EP (1) EP1928501B1 (ro)
JP (1) JP2009509608A (ro)
KR (1) KR20080058389A (ro)
CN (1) CN101316614A (ro)
AU (1) AU2006296350B2 (ro)
BR (1) BRPI0617588A2 (ro)
CA (1) CA2624047C (ro)
CY (1) CY1116161T1 (ro)
DK (1) DK1928501T3 (ro)
ES (1) ES2534416T3 (ro)
HK (1) HK1117420A1 (ro)
HR (1) HRP20150393T1 (ro)
HU (1) HUE024968T2 (ro)
IL (1) IL190323A (ro)
IT (1) ITMI20051826A1 (ro)
MD (1) MD20080116A (ro)
NO (1) NO20081559L (ro)
PL (1) PL1928501T3 (ro)
PT (1) PT1928501E (ro)
RS (1) RS53934B1 (ro)
RU (1) RU2446828C2 (ro)
SI (1) SI1928501T1 (ro)
TN (1) TNSN08144A1 (ro)
UA (1) UA93060C2 (ro)
WO (1) WO2007036792A2 (ro)
ZA (1) ZA200802745B (ro)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011053554A1 (en) * 2009-10-30 2011-05-05 Revance Therapeutics, Inc. Device and method for topical application of therapeutics or cosmetic compositions
EP3238709B1 (en) 2011-04-28 2020-07-01 Platform Brightworks Two, Ltd. Improved parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
CN103508077A (zh) * 2012-06-25 2014-01-15 贵州益佰制药股份有限公司 一种药物包装系统及静脉给药的试剂盒
US20210322304A1 (en) 2018-09-05 2021-10-21 Emcure Pharmaceuticals Ltd. Stable ready-to-use carmustine pharmaceutical composition
US20220062288A1 (en) * 2020-09-02 2022-03-03 Jubilant Pharma Holdings Inc. Pharmaceutical compositions of vibegron for reducing body fat
US20220062213A1 (en) * 2020-09-02 2022-03-03 Jubilant Pharma Holdings Inc. Methods and compositions of solabegron for reducing body fat
WO2023049747A1 (en) * 2021-09-22 2023-03-30 Elanco Us Inc. Streptococcus suis lytic enzyme compositions and methods of use thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3730338A (en) * 1971-03-04 1973-05-01 Kendall & Co Sterile shielded container
US5536413A (en) * 1990-12-03 1996-07-16 Pall Corporation Method for treating a parenteral emulsion-containing medicament fluid
US6232477B1 (en) * 1996-03-25 2001-05-15 Aventis Pharma S.A. Methods of preparing new taxoids and pharmaceutical compositions containing them
JPH105342A (ja) * 1996-06-27 1998-01-13 A S A Sangyo Kk 経腹膜投薬用カテーテル及び投薬容器セット
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
SE9703425D0 (sv) * 1997-09-23 1997-09-23 Pharmacia & Upjohn Ab Prefilled ampooules and manufacture thereof
US6478771B1 (en) * 1998-11-13 2002-11-12 Elan Pharma International Limited Drug delivery systems and methods
AUPQ078799A0 (en) * 1999-06-04 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. New use
HUP0203159A3 (en) 1999-10-18 2004-12-28 Fujisawa Pharmaceutical Co Method for producing liposome preparation, containing pipecolic acid derivative
US6489335B2 (en) * 2000-02-18 2002-12-03 Gholam A. Peyman Treatment of ocular disease
US20030018044A1 (en) * 2000-02-18 2003-01-23 Peyman Gholam A. Treatment of ocular disease
JP2002052067A (ja) * 2000-08-09 2002-02-19 Kyowa Medex Co Ltd 用時薬剤溶解器具、用時溶解型キット製剤用容器及び用時溶解型キット製剤
EP1800670A1 (en) * 2001-04-20 2007-06-27 The University of British Columbia Micellar drug delivery systems for hydrophobic drugs
CA2445763A1 (en) * 2001-05-01 2002-11-07 Angiotech Pharmaceuticals Inc. Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
JP4002747B2 (ja) * 2001-10-26 2007-11-07 株式会社大塚製薬工場 薬剤混合用アダプタおよびそれを備える溶解液容器
GB2388025A (en) 2002-04-06 2003-11-05 Pharmaceutical Bulk Substances Kit for preparing a formulation of paclitaxel
JP4427965B2 (ja) * 2002-07-02 2010-03-10 ニプロ株式会社 連通手段付き薬液容器
US7488309B2 (en) * 2002-07-03 2009-02-10 Bioanalytical Systems, Inc. Device and method for drug delivery to animals
AU2003291458A1 (en) 2002-11-08 2004-06-03 Bristol-Myers Squibb Company Pharmaceutical compositions and methods of using taxane derivatives
US20040224876A1 (en) * 2003-02-14 2004-11-11 Jost-Price Edward Roydon Combination therapy for the treatment of immunoinflammatory disorders
JP2007528402A (ja) * 2004-03-09 2007-10-11 エラン ファーマシューティカルズ，インコーポレイテッド 置換ヒドロキシエチルアミン系のアスパラギン酸プロテアーゼ阻害薬

Also Published As

Publication number Publication date
CY1116161T1 (el) 2017-02-08
WO2007036792A2 (en) 2007-04-05
PT1928501E (pt) 2015-04-23
US8182449B2 (en) 2012-05-22
BRPI0617588A2 (pt) 2011-08-02
RU2008116812A (ru) 2009-11-10
RS53934B1 (en) 2015-08-31
AU2006296350A1 (en) 2007-04-05
HRP20150393T1 (hr) 2015-05-22
WO2007036792A3 (en) 2007-08-30
ZA200802745B (en) 2009-05-27
RU2446828C2 (ru) 2012-04-10
US20090264830A1 (en) 2009-10-22
JP2009509608A (ja) 2009-03-12
TNSN08144A1 (en) 2009-07-14
IL190323A0 (en) 2009-09-22
NO20081559L (no) 2008-06-12
KR20080058389A (ko) 2008-06-25
DK1928501T3 (en) 2015-04-20
EP1928501A2 (en) 2008-06-11
PL1928501T3 (pl) 2015-07-31
HUE024968T2 (en) 2016-02-29
IL190323A (en) 2014-07-31
CA2624047C (en) 2016-01-05
ES2534416T3 (es) 2015-04-22
ITMI20051826A1 (it) 2007-03-30
UA93060C2 (ru) 2011-01-10
CN101316614A (zh) 2008-12-03
AU2006296350B2 (en) 2012-08-30
HK1117420A1 (en) 2009-01-16
EP1928501B1 (en) 2015-01-07
SI1928501T1 (sl) 2015-06-30
CA2624047A1 (en) 2007-04-05

Similar Documents

Publication Publication Date Title
TNSN08144A1 (en) Kit for parenteral administration of medicaments
MX336412B (es) Nuevos analogos de glucagon.
WO2008131056A3 (en) Sustained release monoeximic formulations of opioid and nonopioid analgesics
WO2007130491A3 (en) Patient customized therapeutic regimens
WO2005105014A3 (en) Liquid drug medical device
WO2008131057A3 (en) Sustained release formulations of opioid and nonopioid analgesics
WO2011112229A3 (en) Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
PH12014502058A1 (en) Pharmaceutical composition comprising empagliflozin and antiobesity drug
EP1611880A3 (en) Pharmaceutical formulations for the safe administration of drugs used in the treatment of drug addiction
AR086356A1 (es) Combinacion farmaceutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2
WO2005074547A3 (en) Inflatable porous implants and methods for drug delivery
MX2014002171A (es) Tratamientos de combinacion para hepatitis c.
EP2213318A4 (en) DRUG SOLUTION DELIVERY SYSTEM AND DRUG SOLUTION ADMINISTRATION CANNULA
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
MX336657B (es) Prevencion de hipoglucemia en pacientes con diabetes sacarina de tipo 2.
RS52367B (en) GLATIRAMER ACETATE FORMULATION FORMATED VOLUMES AND APPLICATION PROCEDURES
MX2013011175A (es) Analogos de glucagon novedosos.
WO2012125830A3 (en) Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control
MX2018002223A (es) Derivados de insulina novedosos y usos medicos de los mismos.
WO2008045378A3 (en) Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
MXPA06007510A (es) Composiciones de farmaco y formas de dosis novedosas de topiramato.
WO2012138911A3 (en) Conjugates of anti-hiv drugs and somatostatin analogs
TW200501946A (en) Pharmaceutical composition for the treatment of schizophrenia in a patient with overweight
TW200626133A (en) Oral medication for twice-daily administration

Legal Events

Date Code Title Description
FA9A Abandonment or withdrawal of application (patent for invention)